Marinus Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
0.55
0
(0.09%)
Volume:
260
52 week range:
0.22 - 10.50
Market Cap:
30.352M
Company Description:
Marinus Pharmaceuticals, Inc. offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome.